Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cellular pharmacology of gemcitabine.
Mini E, Nobili S, Caciagli B, Landini I, Mazzei T. Mini E, et al. Among authors: caciagli b. Ann Oncol. 2006 May;17 Suppl 5:v7-12. doi: 10.1093/annonc/mdj941. Ann Oncol. 2006. PMID: 16807468 Free article. Review.
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.
Tempestini A, Caciagli B, Morganti M, Witort E, Nobili S, Papucci L, Schiavone N, Donnini M, Landini I, Lapucci A, Perna F, Lulli M, Mazzei T, Sobrero A, Mini E, Capaccioli S. Tempestini A, et al. Among authors: caciagli b. Oncol Res. 2005;16(3):143-56. doi: 10.3727/000000006783981189. Oncol Res. 2005. PMID: 16925115
Mechanisms of cytotoxicity of selected organogold(III) compounds.
Coronnello M, Mini E, Caciagli B, Cinellu MA, Bindoli A, Gabbiani C, Messori L. Coronnello M, et al. Among authors: caciagli b. J Med Chem. 2005 Oct 20;48(21):6761-5. doi: 10.1021/jm050493o. J Med Chem. 2005. PMID: 16220992
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity.
Coronnello M, Marcon G, Carotti S, Caciagli B, Mini E, Mazzei T, Orioli P, Messori L. Coronnello M, et al. Among authors: caciagli b. Oncol Res. 2000;12(9-10):361-70. doi: 10.3727/096504001108747828. Oncol Res. 2000. PMID: 11697815
Cytotoxic activity of 3-nitropyrazolo[5,1-c][1,2,4]benzotriazine derivatives: a new series of anti-proliferative agents.
Coronnello M, Ciciani G, Mini E, Guerrini G, Caciagli B, Selleri S, Costanzo A, Mazzei T. Coronnello M, et al. Among authors: caciagli b. Anticancer Drugs. 2005 Jul;16(6):645-51. doi: 10.1097/00001813-200507000-00009. Anticancer Drugs. 2005. PMID: 15930893
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I.
Ottanà R, Carotti S, Maccari R, Landini I, Chiricosta G, Caciagli B, Vigorita MG, Mini E. Ottanà R, et al. Among authors: caciagli b. Bioorg Med Chem Lett. 2005 Sep 1;15(17):3930-3. doi: 10.1016/j.bmcl.2005.05.093. Bioorg Med Chem Lett. 2005. PMID: 15993594
Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides.
Morganti M, Coronnello M, Caciagli B, Biondi C, Quattrone A, Capaccioli S, Mazzei T, Mini E. Morganti M, et al. Among authors: caciagli b. Anticancer Drugs. 2000 Apr;11(4):285-94. doi: 10.1097/00001813-200004000-00010. Anticancer Drugs. 2000. PMID: 10898545
Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages.
Dello Sbarba P, Rovida E, Caciagli B, Nencioni L, Labardi D, Paccagnini A, Savini L, Cipolleschi MG. Dello Sbarba P, et al. Among authors: caciagli b. J Leukoc Biol. 1996 Nov;60(5):644-50. doi: 10.1002/jlb.60.5.644. J Leukoc Biol. 1996. PMID: 8929556
Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages.
Dello Sbarba P, Nencioni L, Labardi D, Rovida E, Caciagli B, Cipolleschi MG. Dello Sbarba P, et al. Among authors: caciagli b. Cytokine. 1996 Jun;8(6):488-94. doi: 10.1006/cyto.1996.0066. Cytokine. 1996. PMID: 8818546
Feedback